The Lancet Microbe article summarizes discussions by the Surveillance and Epidemiology of Drug-resistant Infections Consortium on using genomics for antimicrobial resistance surveillance, highlighting its benefits and challenges and providing key recommendations for effective implementation.
The megaround rebound: Private biotechs rack up $100M+ financings
Big money is back. Over the past 12 weeks, biotech startups have raised $100 million-plus megarounds from venture capitalists at a pace that could approach